Maryland Heights, MO, United States of America

Anthony Mannino

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **The Innovative Journey of Anthony Mannino**

Introduction

Anthony Mannino, an accomplished inventor based in Maryland Heights, Missouri, has made significant contributions to the field of pharmaceuticals with his six granted patents. His innovative work focuses on improving synthesis methods for vital compounds, demonstrating a commitment to advancing drug development processes.

Latest Patents

Among his recent breakthroughs, Mannino’s patent titled "Use of Oripavine as a Starting Material for Buprenorphine" stands out. This patent outlines a novel method for synthesizing norbuprenorphine and ultimately buprenorphine by utilizing oripavine as the starting material. Unlike conventional methods that require an O-demethylation step using thebaine, Mannino's approach is more efficient, as oripavine lacks the O-3 methyl group, leading to higher yields.

Another notable patent from Mannino is the "Process for Preparing Morphinan-6-One Products with Low Levels of α,β-Unsaturated Ketone Compounds." This invention details a process aimed at producing highly pure morphinan-6-one products by significantly reducing impurities found in these compounds through the treatment with sulfur-containing preparations.

Career Highlights

Currently, Anthony Mannino is employed at Mallinckrodt, Inc., a globally recognized leader in the pharmaceutical industry. His role allows him to leverage his expertise in organic chemistry and pharmacological applications, contributing to the development of essential drugs. Mannino's innovative patents not only enhance product quality but also improve manufacturing efficiencies in the pharmaceutical sector.

Collaborations

Throughout his career, Mannino has collaborated with notable colleagues, including Henry J. Buehler and William E. Dummitt. These partnerships have facilitated the exchange of ideas and knowledge, leading to advancements in their shared field. Together, they have worked on various projects that continue to push the boundaries of pharmaceutical innovation.

Conclusion

Anthony Mannino's contributions to pharmaceutical science reflect a deep understanding of synthesis methodologies and their impact on drug production. With six patents to his name and ongoing collaborations at Mallinckrodt, Inc., Mannino exemplifies the spirit of innovation required to drive progress in the industry. His work not only provides valuable insights for future developments but also cements his status as a prominent inventor in the realm of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…